Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
21 02 2020
Historique:
received: 04 10 2019
accepted: 18 12 2019
pubmed: 25 12 2019
medline: 22 12 2020
entrez: 25 12 2019
Statut: epublish

Résumé

The emergence of

Identifiants

pubmed: 31871081
pii: AAC.02005-19
doi: 10.1128/AAC.02005-19
pmc: PMC7038236
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Penicillins 0
Ciprofloxacin 5E8K9I0O4U
Ceftriaxone 75J73V1629
Azithromycin 83905-01-5
Cefixime 97I1C92E55
Tetracycline F8VB5M810T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Crown copyright 2020.

Références

Antimicrob Agents Chemother. 2002 Sep;46(9):3020-5
pubmed: 12183262
J Clin Microbiol. 2015 Jul;53(7):2042-8
pubmed: 25878350
Sex Transm Dis. 2013 Nov;40(11):877-9
pubmed: 24113412
Antimicrob Agents Chemother. 2005 Jan;49(1):137-43
pubmed: 15616287
Mol Microbiol. 1994 Oct;14(2):371-80
pubmed: 7830580
J Antimicrob Chemother. 2017 Jul 1;72(7):1937-1947
pubmed: 28333355
Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45
pubmed: 21576437
Indian J Ophthalmol. 2008 Jan-Feb;56(1):45-50
pubmed: 18158403
Lancet Infect Dis. 2013 Sep;13(9):762-8
pubmed: 23764300
J Clin Microbiol. 2015 Nov;53(11):3646-9
pubmed: 26338862
JAMA. 2013 Jan 9;309(2):163-70
pubmed: 23299608
Mol Microbiol. 2008 Oct;70(2):462-78
pubmed: 18761689
Expert Opin Pharmacother. 2012 Jul;13(10):1411-20
pubmed: 22646654
J Clin Microbiol. 2015 Jan;53(1):191-200
pubmed: 25378573
Expert Opin Pharmacother. 2009 Mar;10(4):555-77
pubmed: 19284360
J Antimicrob Chemother. 2003 Jan;51(1):131-3
pubmed: 12493797
Sex Transm Infect. 2017 Feb;93(1):65-67
pubmed: 26968786
Antimicrob Agents Chemother. 2013 Jul;57(7):3029-36
pubmed: 23587946
Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51
pubmed: 19528266
Curr Opin Infect Dis. 2016 Feb;29(1):45-51
pubmed: 26658656
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv42-6
pubmed: 24243879
Sex Transm Infect. 2010 Nov;86(6):454-60
pubmed: 20940159
Antimicrob Agents Chemother. 2007 Sep;51(9):3111-6
pubmed: 17591846
Sex Transm Dis. 2018 Feb;45(2):92-95
pubmed: 29329177
Antimicrob Agents Chemother. 1999 Oct;43(10):2468-72
pubmed: 10508026
Biochemistry. 2017 Feb 28;56(8):1140-1150
pubmed: 28145684
Expert Rev Anti Infect Ther. 2014 Jun;12(6):653-6
pubmed: 24702589
J Bacteriol. 2006 Apr;188(7):2300-8
pubmed: 16547016
J Antimicrob Chemother. 2010 Dec;65(12):2543-7
pubmed: 20940180
J Antimicrob Chemother. 2016 Nov;71(11):3096-3108
pubmed: 27432602
Antimicrob Agents Chemother. 2006 Nov;50(11):3638-45
pubmed: 16940068
mBio. 2018 Nov 27;9(6):
pubmed: 30482834
Sex Transm Infect. 1999 Feb;75(1):60-6
pubmed: 10448346
J Clin Microbiol. 2016 May;54(5):1304-13
pubmed: 26935729
Int J Antimicrob Agents. 1999 Aug;12(4):325-32
pubmed: 10493609
Sex Transm Infect. 2010 Nov;86(6):415-21
pubmed: 20656721
Antimicrob Agents Chemother. 2005 Oct;49(10):4327-34
pubmed: 16189114
Antimicrob Agents Chemother. 2010 Sep;54(9):3812-6
pubmed: 20585125
J Clin Microbiol. 2015 Nov;53(11):3606-8
pubmed: 26292300
Clin Microbiol Rev. 2014 Jul;27(3):587-613
pubmed: 24982323
Antimicrob Agents Chemother. 2002 Mar;46(3):769-77
pubmed: 11850260
Biochemistry. 2010 Sep 21;49(37):8062-70
pubmed: 20704258
Sex Transm Infect. 2018 Nov;94(7):479-482
pubmed: 29674407
Antimicrob Agents Chemother. 2007 Jun;51(6):2117-22
pubmed: 17420216
Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80
pubmed: 22155830
Clin Infect Dis. 2017 Jul 1;65(1):37-45
pubmed: 28510723
J Infect Chemother. 2008 Jun;14(3):195-203
pubmed: 18574654
Future Microbiol. 2012 Dec;7(12):1401-22
pubmed: 23231489
J Mol Diagn. 2013 Jan;15(1):116-29
pubmed: 23159594
J Infect Dis. 2016 Nov 15;214(10):1579-1587
pubmed: 27638945
Mol Biol (Mosk). 2014 Nov-Dec;48(6):977-82
pubmed: 25845238
J Antimicrob Chemother. 2010 Apr;65(4):669-75
pubmed: 20093260

Auteurs

Walter Demczuk (W)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada walter.demczuk@canada.ca.

Irene Martin (I)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Pam Sawatzky (P)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Vanessa Allen (V)

Public Health Ontario Laboratories, Toronto, Ontario, Canada.

Brigitte Lefebvre (B)

Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.

Linda Hoang (L)

British Columbia Centres for Disease Control Public Health Microbiology & Reference Laboratory, Vancouver, British Columbia, Canada.

Prenilla Naidu (P)

Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.

Jessica Minion (J)

Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada.

Paul VanCaeseele (P)

Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.

David Haldane (D)

Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.

David W Eyre (DW)

Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom.
Oxford National Institute for Health Research Health Protection Research Unit, Oxford, United Kingdom.

Michael R Mulvey (MR)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Genome, Viral Ralstonia Composting Solanum lycopersicum Bacteriophages
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH